PharmaCyte Biotech
PMCB
PMCB
23 hedge funds and large institutions have $420K invested in PharmaCyte Biotech in 2025 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
34% less capital invested
Capital invested by funds: $632K → $420K (-$212K)
Holders
23
Holding in Top 10
–
Calls
$10K
Puts
–
Top Buyers
| 1 | +$29.3K | |
| 2 | +$14.1K | |
| 3 | +$2.68K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$1K |
| 5 |
Morgan Stanley
New York
|
+$9 |
Top Sellers
| 1 | -$116K | |
| 2 | -$30.4K | |
| 3 | -$22.3K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$20.6K |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$3.56K |
